<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03166930</url>
  </required_header>
  <id_info>
    <org_study_id>B2507-R</org_study_id>
    <secondary_id>I01RX002507</secondary_id>
    <nct_id>NCT03166930</nct_id>
  </id_info>
  <brief_title>Evaluation of a Spasticity Management Program for People With Multiple Sclerosis</brief_title>
  <acronym>STC</acronym>
  <official_title>Evaluation of a Spasticity Management Program for People With Multiple Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the impacts of two different methods of managing MS-related
      spasticity of the lower limbs. Both interventions will be presented as group classes
      consisting of exercises to reduce spasticity.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomized to receive one of two exercise programs. Participants will not be masked regarding which group they are in, but they will not be told which group is considered standard of care and which is the intervention.</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of spasticity, measured by the Multiple Sclerosis Spasticity Scale-88</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Impact of spasticity will be measured using the Multiple Sclerosis Spasticity Scale-88 at one month post intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Severity of spasticity, measured by the Numeric Rating Scale for Spasticity</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Severity of spasticity will be measured using the Numeric Rating Scale for Spasticity at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue, measured by the Modified Fatigue Impact Scale</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Fatigue will be measured using the Modified Fatigue Impact Scale at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality and quantity, measured by the Pittsburge Sleep Quality Index</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Sleep quality and quantity will be measured using Pittsburgh Sleep Quality Index at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on day-to-day life, measured by the Multiple Sclerosis Impact Scale-29</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Impact on day-to-day life, measured by the Multiple Sclerosis Impact Scale-29 at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS Item Bank v1.0 - Emotional Distress - Depression-Short Form 8a</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Emotional Distress - Depression will be measured using PROMIS Item Bank v1.0 - Emotional Distress - Depression-Short Form 8a at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on multiple sclerosis on walking, measured by the Multiple Sclerosis Walking Scale-12</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Impact on multiple sclerosis on walking, measured by the Multiple Sclerosis Walking Scale-12 at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking measured by the Timed 25 Foot Walk</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Walking will be measured using the Timed 25 Foot Walk at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking and turning measured by the Timed Up and Go</measure>
    <time_frame>One month post-intervention</time_frame>
    <description>Walking and turning measured by the Timed Up and Go will be measured at one month post intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain severity and interference</measure>
    <time_frame>One month post intervention</time_frame>
    <description>Pain severity and interference measured by a modified version of the Brief Pain Inventory at one month post intervention.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Spasticity Take Control</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will attend two 2-hour classes, one week apart, consisting of education and a stretching program for spasticity management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stretching for People with MS: An Illustrated Manual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will attend two 2-hour classes, one week apart, consisting of education and exercises for spasticity management.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Spasticity Take Control</intervention_name>
    <description>Participants will attend two 2-hour classes, one week apart, consisting of education and a stretching program for spasticity management.</description>
    <arm_group_label>Spasticity Take Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stretching for People with MS: An Illustrated Manual</intervention_name>
    <description>Participants will attend two 2-hour classes, one week apart, consisting of education and exercises for spasticity management from the manual.</description>
    <arm_group_label>Stretching for People with MS: An Illustrated Manual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A diagnosis of definite MS by 2010 updated McDonald Criteria

          -  Able to walk 25 feet with any assistive devices (Patient Determined Disease Steps 0-6)

          -  Fluent in written and spoken English, as materials are not validated in languages
             other than English.

          -  Presence of self-reported lower extremity spasticity that is interfering with daily
             activities, using the NARCOMS definition

        Exclusion Criteria:

          -  Any uncontrolled medical or mental condition that would limit participation or
             completion of the study

          -  Any self-reported musculoskeletal or neurological condition other than MS that is
             known to cause spasticity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lucinda L. Hugos, PT MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Portland Health Care System, Portland, OR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sandra K Joos, PhD MPH</last_name>
    <phone>(503) 220-8262</phone>
    <phone_ext>58329</phone_ext>
    <email>sandra.joos@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Portland Health Care System, Portland, OR</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucinda L Hugos, PT MS</last_name>
      <phone>503-220-8262</phone>
      <phone_ext>52338</phone_ext>
      <email>cinda.hugos@va.gov</email>
    </contact>
    <investigator>
      <last_name>Lucinda L. Hugos, PT MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>May 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>April 22, 2020</last_update_submitted>
  <last_update_submitted_qc>April 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Muscle Spasticity</keyword>
  <keyword>Muscle Stretching Exercises</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Spasticity</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

